Bad blood: secrets and lies in a Silicon Valley startup
(CD Audiobook)
Description
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When the author, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both the author and the newspaper were threatened with lawsuits. Undaunted, the paper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. The biggest corporate fraud since Enron is a cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley.--adapted from publisher's description.
Copies
More Details
Notes
Reviews from GoodReads
Citations
Carreyrou, J., & Damron, W. (2018). Bad blood: secrets and lies in a Silicon Valley startup. Unabridged. Random House Audio.
Chicago / Turabian - Author Date Citation (style guide)Carreyrou, John and Will, Damron. 2018. Bad Blood: Secrets and Lies in a Silicon Valley Startup. Random House Audio.
Chicago / Turabian - Humanities Citation (style guide)Carreyrou, John and Will, Damron, Bad Blood: Secrets and Lies in a Silicon Valley Startup. Random House Audio, 2018.
MLA Citation (style guide)Carreyrou, John, and Will Damron. Bad Blood: Secrets and Lies in a Silicon Valley Startup. Unabridged. Random House Audio, 2018.
Staff View
Record Information
| Last Sierra Extract Time | Jun 23, 2025 06:55:49 PM |
|---|---|
| Last File Modification Time | Jun 23, 2025 06:56:07 PM |
| Last Grouped Work Modification Time | Jul 05, 2025 10:18:25 PM |
MARC Record
| LEADER | 03314cim a2200481Ii 4500 | ||
|---|---|---|---|
| 001 | ocm04153229 | ||
| 003 | OCoLC | ||
| 005 | 20250210225055.0 | ||
| 007 | sd fmngnnmmned | ||
| 008 | 190123s2018 nyunnnne z n eng d | ||
| 019 | |a 1084401242 | ||
| 020 | |a 9780593105061 | ||
| 020 | |a 0593105060 | ||
| 040 | |a TOH |b eng |c TOH |d OCLCQ |d TEF |d BLACP |d BIB |d WD | ||
| 043 | |a n-us--- | ||
| 082 | 0 | 4 | |a 338.7/681761 |2 23 |
| 100 | 1 | |a Carreyrou, John, |e author. |0 http://id.loc.gov/authorities/names/n2018014999 | |
| 245 | 1 | 0 | |a Bad blood : |b secrets and lies in a Silicon Valley startup / |c John Carreyrou. |
| 246 | 3 | 0 | |a Secrets and lies in a Silicon Valley startup |
| 250 | |a Unabridged. | ||
| 264 | 1 | |a New York, NY : |b Random House Audio, |c ℗2018. | |
| 300 | |a 9 audio discs (11 1/2 hr.) ; |c 12 cm | ||
| 336 | |a spoken word |b spw |2 rdacontent | ||
| 337 | |a audio |b s |2 rdamedia | ||
| 338 | |a audio disc |b sd |2 rdacarrier | ||
| 500 | |a Title from container | ||
| 511 | 1 | |a Read by Will Damron. | |
| 520 | |a In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When the author, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both the author and the newspaper were threatened with lawsuits. Undaunted, the paper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. The biggest corporate fraud since Enron is a cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley.--adapted from publisher's description. | ||
| 538 | |a Compact discs. | ||
| 600 | 1 | 0 | |a Holmes, Elizabeth, |d 1984- |0 http://id.loc.gov/authorities/names/no2018096428 |
| 610 | 2 | 0 | |a Theranos (Firm) |x History. |
| 650 | 0 | |a Hematologic equipment industry |z United States. | |
| 650 | 0 | |a New business enterprises |x Corrupt practices |z United States |v Case studies. | |
| 650 | 0 | |a Securities fraud |z United States |v Case studies. | |
| 655 | 7 | |a Audiobooks. |2 lcgft |0 http://id.loc.gov/authorities/genreForms/gf2011026063 | |
| 700 | 1 | |a Damron, Will, |e narrator. |0 http://id.loc.gov/authorities/names/n2014066072 | |
| 907 | |a .b26129632 | ||
| 945 | |y .i62829403 |i 31216003996779 |l nhakg |s - |h |u 4 |x 0 |w 0 |v 2 |t 3 |z 05-20-19 |r - |o - |a Audiobook 338.7681 Carreyrou, John | ||
| 945 | |y .i62863915 |i 31200080909327 |l hmabc |s - |h |u 8 |x 0 |w 0 |v 1 |t 3 |z 05-29-19 |r - |o - |a CD/TBK/338.768/CAR | ||
| 945 | |y .i63020348 |i 20503405423 |l guabc |s - |h |u 10 |x 0 |w 0 |v 1 |t 3 |z 07-02-19 |r - |o - |a BKCD 338.76 CARREYROU | ||
| 945 | |y .i63180765 |i 22702184858 |l dugmm |s - |h |u 8 |x 0 |w 0 |v 7 |t 3 |z 08-12-19 |r - |o - |a BCD 338.7 CAR | ||
| 945 | |y .i64167288 |i 20702952431 |l brabc |s - |h |u 4 |x 2 |w 0 |v 0 |t 3 |z 06-03-20 |r - |o - |a BCD 338 CAR | ||
| 998 | |e - |d i |f eng |a br |a du |a gu |a hm |a nh | ||